Genevieve M. Halpenny, PhD

Special Counsel

Services & Specializations

Admissions

California;
Delaware;
New York;
US Court of Appeals, Federal Circuit;
US Patent & Trademark Office;
USDC, Central District of California;
USDC, Colorado;
USDC, District of Delaware;
USDC, Northern District of California

Address

12544 High Bluff Drive, Suite 400, San Diego, CA 92130

Office Tel.

858.480.8233

VCard

Overview

Genevieve brings clients extensive experience in intellectual property strategy, patent prosecution, and complex IP litigation. She has drafted and prosecuted patents directed to technologies including chimeric proteins, RNA affinity filtration purification ligands, materials, and systems, systems for making conductive textiles, and endoscope cleaning systems. Previously a patent attorney with ADARx Pharmaceuticals, she partnered with scientists and senior leadership on patent portfolio development, siRNA technologies, and IP risk management. Genevieve has also worked previously in private practice, advising clients on patent and trademark strategies, due diligence, licensing, and enforcement.

Barclay Damon Pro Bono Award, Barclay Damon LLP, 2023
Distinguished Pro Bono Service Award, Volunteer Lawyers Project of CNY, Inc., 2023

JD, UC Hastings College of the Law, 2014
PhD (Inorganic & Polymer Chemistry, Materials Science, Biotechnology), University of California Santa Cruz, Santa Cruz, CA, 2011
BS (Chemical Engineering, Biotechnology Option), University of California Berkeley, Berkeley, CA, 2004

Co-author. “How Executives’ Deposition Standards Can Differ,” Law360 Expert Analysis, October 23, 2023.
Author. “Pay for Delay Settlements in Pharmaceutical Cases,” American Chemical Society Western Regional Meeting, November 7, 2015.
Co-author. “Nitric Oxide (NO)-Induced Death of Gram-Negative Bacteria from a Light-Controlled NO-Releasing Platform,” 9 Chemistry & Biodiversity 1829–39, 2012.
Co-author. “Eradication of Pathogenic Bacteria by Remote Delivery of Nitric Oxide via Light-Triggering of Nitrosyl-Containing Materials,” 1 ACS Med Chem Letters 180–83, 2010.
Co-author. “Characterization of pHEMA-based Hydrogels that Exhibit Light-induced Bactericidal Effects via Release of NO,” 20 J Mater Sci: Mater Med 2353–60, 2009.
Author. “Accelerated Photorelease of NO from {Ru-NO}6 Nitrosyls Containing Carboxamido-N and Carboxylato-O Donors: Synthesis, Structures, and Photochemistry,” 48 Inorganic Chemistry 1490–97, 2009.

American Intellectual Property Law Association, member, 2023-present
San Diego Intellectual Property Law Association, member, 2024-present
Hon. David E. Peebles Inn of Court, Chair of Programming, 2021-2024

‌

‌
‌

‌

‌
‌
‌
‌

‌
‌

‌
‌
‌

‌
‌

Thought Leadership

Co-author. “How Executives’ Deposition Standards Can Differ,” Law360 Expert Analysis, October 23, 2023.
Author. “Pay for Delay Settlements in Pharmaceutical Cases,” American Chemical Society Western Regional Meeting, November 7, 2015.
Co-author. “Nitric Oxide (NO)-Induced Death of Gram-Negative Bacteria from a Light-Controlled NO-Releasing Platform,” 9 Chemistry & Biodiversity 1829–39, 2012.
Co-author. “Eradication of Pathogenic Bacteria by Remote Delivery of Nitric Oxide via Light-Triggering of Nitrosyl-Containing Materials,” 1 ACS Med Chem Letters 180–83, 2010.
Co-author. “Characterization of pHEMA-based Hydrogels that Exhibit Light-induced Bactericidal Effects via Release of NO,” 20 J Mater Sci: Mater Med 2353–60, 2009.
Author. “Accelerated Photorelease of NO from {Ru-NO}6 Nitrosyls Containing Carboxamido-N and Carboxylato-O Donors: Synthesis, Structures, and Photochemistry,” 48 Inorganic Chemistry 1490–97, 2009.

Services & Specializations

Admissions

Address

Office Tel.

Overview

Recognitions

Education

Thought Leadership

Community

Services & Specializations

Admissions

Address

Office Tel.

Overview

Recognitions

Education

Thought Leadership

Community